AtriCure (ATRC)
(Delayed Data from NSDQ)
$34.41 USD
-0.69 (-1.97%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $34.39 -0.02 (-0.06%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, AtriCure, Inc. has a market cap of $1.74B, which represents its share price of $35.10 multiplied by its outstanding shares number of 49.70M. As a small-cap company, ATRC's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ATRC 34.41 -0.69(-1.97%)
Will ATRC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ATRC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ATRC
AtriCure (ATRC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
AtriCure (ATRC) Reports Q2 Loss, Tops Revenue Estimates
ATRC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Abbott (ABT) Q2 Earnings and Revenues Top Estimates
Has Amneal Pharmaceuticals (AMRX) Outpaced Other Medical Stocks This Year?
Are Medical Stocks Lagging Astellas Pharma (ALPMY) This Year?
Other News for ATRC
Bullish Two Hundred Day Moving Average Cross - ATRC
Decoding AtriCure Inc (ATRC): A Strategic SWOT Insight
AtriCure (ATRC) Price Target Raised Following Strong Quarterly Results
AtriCure (ATRC) Price Target Uplifted by Canaccord Analyst
AtriCure (ATRC): Needham Analyst Raises Price Target to $45 | ATRC Stock News